TC
TVM Capital
Private EquityActiveTVM Capital is a global venture and growth capital firm that aims to finance select biopharmaceutical and medical device companies.
95
Investments
5
Exits
$1.7B
AUM
5.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for TVM Capital.
Investment Thesis & Strategy
TVM Capital invests in various stages of biopharmaceutical and medical device companies globally, providing venture and growth capital.
Investment Activity
Deals per year over the last 15 years
1
20071
20080
20091
20100
20110
20120
20132
20140
20151
20161
20170
20180
20191
20201
2021Portfolio Companies
Selected investments from their portfolio of 95 companies
X
Xenocor
Healthcare · Series A, 2021
A
Ablatus Therapeutics
Biotech · Series A, 2020
I
InnoPharma
Biotech · Growth, 2017
I
Iterum Therapeutics
Biotech · Growth, 2016
S
Sequana Medical
Healthcare · Growth, 2014
i
iCAD
Healthcare · Growth, 2014
G
GI Dynamics
Healthcare · Growth, 2010
B
Bioness
Healthcare · Growth, 2008
C
ConforMIS
Healthcare · Growth, 2007
Notable Exits
CompanyTypeYearValue / Acquirer
SymphogenAcquisition2020—
BiotestAcquisition2020—
CellnovoAcquisition2019—
X-FABIPO2015—
AmedesAcquisition2013—
Frequently Asked Questions
TVM Capital focuses on Series B, Series C+ stage investments.